Paid Clinical Trials in Texas

Texas has 5,499 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 19, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

5,499 clinical trials

↓ Download CSV

A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

for Generalized Myasthenia Gravis

Drug: Efgartigimod PH20 SC

3 locations incl. Charlotte

Sponsor: argenx

Sex: All·Age: 2 - 17

Code: NCT06392386·Phase 2, Phase 3·Recruiting

Apply to this trial

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

for Atrial Fibrillation

43 locations incl. Phoenix

Sponsor: Biosense Webster, Inc.

Sex: All·Age: 18 - 80

Code: NCT06455098·Recruiting

Apply to this trial

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

for Advanced Prostate Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06369246·Phase 1·Recruiting

Apply to this trial

Paper-Based and Smartphone-Based Memory Supports

for Alzheimer Disease

3 locations incl. Austin

Sponsor: Baylor University

Sex: All·Age: 50+

Code: NCT06444841·Recruiting

Apply to this trial

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

for Carcinoma, Pancreatic Ductal

26 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06447662·Phase 1·Recruiting

Apply to this trial

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

for Mesothelioma

1 location in Houston

Sponsor: BridGene Biosciences Inc.

Sex: All·Age: 18+

Code: NCT06452160·Phase 1·Recruiting

Apply to this trial

Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry

for Major Depressive Disorder

2 locations incl. Encinitas

Sponsor: Biomedical Discoveries and Neuroscientific Foundations LLC

Sex: All·Age: 12+

Code: NCT06512324·Enrolling By Invitation

BiVACOR® Total Artificial Heart Early Feasibility Study

for Heart Failure

4 locations incl. Phoenix

Sponsor: BiVACOR Inc.

Sex: All·Age: 18 - 70

Code: NCT06174103·Recruiting

Apply to this trial

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for Rectal Cancer

101 locations incl. Phoenix

Sponsor: Canadian Cancer Trials Group

Sex: All·Age: 18+

Code: NCT06205485·Phase 3·Recruiting

Apply to this trial

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

for Lymphodepleting Chemotherapy

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 80

Code: NCT06383572·Phase 1, Phase 2·Recruiting

Apply to this trial

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

for Head and Neck Cancer

5 locations incl. Kansas City

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 18+

Code: NCT06030011·Recruiting

Apply to this trial

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for Stage II Nasopharyngeal Carcinoma AJCC v8

Drug: Nivolumab

76 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 21

Code: NCT06064097·Phase 2·Recruiting

Apply to this trial

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

for Cardiovascular Risk

Drug: Ziltivekimab

208 locations incl. Alexander City

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT06118281·Phase 3·Recruiting

Apply to this trial

Humidity in Incubators for Tiny Infants

for Extremely Premature Infant

6 locations incl. Columbus

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 0 Days - 1 Day

Code: NCT06399861·Recruiting

Apply to this trial

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

for Endometrial Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06409052·Recruiting

Apply to this trial

Accelerated rTMS for Substance Use Disorder and Depression

for Stimulant Use

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 65

Code: NCT06424184·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

for Moderate to Severe Plaque Psoriasis

Drug: Bimekizumab

9 locations incl. Fountain Valley

Sponsor: UCB Biopharma SRL

Sex: All·Age: 6 - 17

Code: NCT06425549·Phase 3·Recruiting

Apply to this trial

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for Generalized Myasthenia Gravis

21 locations incl. Phoenix

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All·Age: 18+

Code: NCT06463587·Phase 3·Recruiting

Apply to this trial

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for Transthyretin Amyloidosis

30 locations incl. La Jolla

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06465810·Recruiting

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

61 locations incl. Mobile

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06496178·Phase 3·Recruiting

Apply to this trial

External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial

for Severe Traumatic Brain Injury

6 locations incl. Gainesville

Sponsor: Brain Trauma Foundation

Sex: All·Age: 18 - 65

Code: NCT05889650·Recruiting

Apply to this trial

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

for Acute Respiratory Distress Syndrome

33 locations incl. Tucson

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT06066502·Phase 3·Recruiting

Apply to this trial

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for Advanced Esophageal Adenocarcinoma

Drug: Nivolumab

372 locations incl. Little Rock

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06203600·Phase 2, Phase 3·Recruiting

Apply to this trial

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced or Metastatic Solid Tumors

8 locations incl. San Diego

Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All·Age: 18+

Code: NCT06307795·Phase 1·Recruiting

Apply to this trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for Triple-Negative Breast Cancer

88 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06393374·Phase 3·Recruiting

Apply to this trial

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

for Langerhans Cell Histiocytosis

Drug: Trametinib

1 location in Fort Worth

Sponsor: Cook Children's Health Care System

Sex: All·Age: 1 - 30

Code: NCT06582745·Phase 2·Recruiting

Apply to this trial

KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure

for Pediatric Intestinal Failure

8 locations incl. Boston

Sponsor: SterileCare Inc.

Sex: All·Age: 4 Weeks - 18

Code: NCT05879835·Recruiting

Apply to this trial

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

for Peripheral Arterial Disease

20 locations incl. Scottsdale

Sponsor: Avantec Vascular

Sex: All·Age: 18+

Code: NCT06321575·Recruiting

Apply to this trial

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

for Colorectal Cancer

13 locations incl. Los Angeles

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06428409·Phase 1, Phase 2·Recruiting

Apply to this trial

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

for Stargardt Disease

8 locations incl. San Francisco

Sponsor: Ascidian Therapeutics, Inc

Sex: All·Age: 5+

Code: NCT06445322·Recruiting

Apply to this trial

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for Polymyositis, Dermatomyositis

43 locations incl. Phoenix

Sponsor: AstraZeneca

Sex: All·Age: 18 - 75

Code: NCT06455449·Phase 3·Recruiting

Apply to this trial

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

for Glioblastoma

Drug: Niraparib

32 locations incl. Birmingham

Sponsor: Ivy Brain Tumor Center

Sex: All·Age: 18+

Code: NCT06388733·Phase 3·Recruiting

Apply to this trial

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

for Bipolar Disorder, Manic

23 locations incl. Rogers

Sponsor: Intra-Cellular Therapies, Inc.

Sex: All·Age: 18 - 75

Code: NCT06462586·Phase 3·Recruiting

Apply to this trial

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for Leukemia

13 locations incl. Duarte

Sponsor: BlossomHill Therapeutics

Sex: All·Age: 18+

Code: NCT06501196·Phase 1·Recruiting

Apply to this trial

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

for Cancer

1 location in Houston

Sponsor: The Methodist Hospital Research Institute

Sex: All·Age: 18+

Code: NCT07290491·Phase 3·Recruiting

Apply to this trial

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for Acute Myeloid Leukemia

335 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05564390·Phase 2·Recruiting

Apply to this trial

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

for Colorectal Cancer

9 locations incl. Duarte

Sponsor: Apollo Therapeutics Ltd

Sex: All·Age: 18+

Code: NCT06399757·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for Advanced Solid Tumor

13 locations incl. New Haven

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT06463340·Phase 1·Recruiting

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

60 locations incl. Gilbert

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting

Apply to this trial

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

for Sickle Cell Disease

16 locations incl. Oakland

Sponsor: Editas Medicine, Inc.

Sex: All·Age: 12 - 50

Code: NCT06363760·Enrolling By Invitation